Ortho Clinical Diagnostics Holdings Plc (OCD), a subsidiary of Quidelortho Corp, designs, develops, manufactures and markets diagnostic instruments, assays. It offers its products and solutions to hospitals, clinical laboratories, blood, and plasma centers across the world. The company’s products include clinical chemistry products used for measurement of target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; and Immunoassays for measurement of proteins, antibodies, and markers; donor screening and immunohematology products for blood and plasma screening. The company operates manufacturing facilities, distribution, and training centers in the US, Japan, and France. OCD is headquartered in Raritan, New Jersey, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Ortho Clinical Diagnostics Holdings Plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Ortho Clinical Diagnostics Holdings Plc Company Overview
- Ortho Clinical Diagnostics Holdings Plc Company Snapshot
- Ortho Clinical Diagnostics Holdings Plc Pipeline Products and Ongoing Clinical Trials Overview
- Ortho Clinical Diagnostics Holdings Plc - Pipeline Analysis Overview
- Business Description
- Ortho Clinical Diagnostics Holdings Plc - Key Facts
- Ortho Clinical Diagnostics Holdings Plc - Major Products and Services
- Ortho Clinical Diagnostics Holdings Plc Pipeline Products by Development Stage
- Ortho Clinical Diagnostics Holdings Plc Pipeline Products Overview
- Diagnostic Assay - Thyroid Diseases
- Diagnostic Assay - Thyroid Diseases Product Overview
- Enhanced Chemiluminescent High Sensitivity Troponin I Assay
- Enhanced Chemiluminescent High Sensitivity Troponin I Assay Product Overview
- Next Generation Circulating Tumor Cell Test
- Next Generation Circulating Tumor Cell Test Product Overview
- Next Generation VITROS System
- Next Generation VITROS System Product Overview
- ORTHO AutoVue - Rare Sera Assay
- ORTHO AutoVue - Rare Sera Assay Product Overview
- ORTHO BioVue - Rare Sera Assay
- ORTHO BioVue - Rare Sera Assay Product Overview
- ProMu
- ProMu Product Overview
- VITROS 3600 Immunodiagnostic System - High Sensitivity Troponin Assay
- VITROS 3600 Immunodiagnostic System - High Sensitivity Troponin Assay Product Overview
- VITROS 3600 Integrated System - Nephrocheck Assay
- VITROS 3600 Integrated System - Nephrocheck Assay Product Overview
- VITROS 3600 System With Power Processor
- VITROS 3600 System With Power Processor Product Overview
- VITROS 4600 - CRP Ultra (MP) Assay
- VITROS 4600 - CRP Ultra (MP) Assay Product Overview
- VITROS 5600 - CRP Ultra (MP) Assay
- VITROS 5600 - CRP Ultra (MP) Assay Product Overview
- VITROS 5600 Integrated System - High Sensitivity Troponin Assay
- VITROS 5600 Integrated System - High Sensitivity Troponin Assay Product Overview
- VITROS 5600 Integrated System - Nephrocheck Assay
- VITROS 5600 Integrated System - Nephrocheck Assay Product Overview
- VITROS Anti-SARS-CoV-2 IgG Test
- VITROS Anti-SARS-CoV-2 IgG Test Product Overview
- VITROS ECi/ECiQ Immunodiagnostic System - High Sensitivity Troponin Assay
- VITROS ECi/ECiQ Immunodiagnostic System - High Sensitivity Troponin Assay Product Overview
- VITROS XT 7600 Integrated System - Alpha-1 Acid Glycoprotein Assay
- VITROS XT 7600 Integrated System - Alpha-1 Acid Glycoprotein Assay Product Overview
- VITROS XT 7600 Integrated System - Alpha-2 Macroglobulin Assay
- VITROS XT 7600 Integrated System - Alpha-2 Macroglobulin Assay Product Overview
- VITROS XT 7600 Integrated System - Chagas Assay
- VITROS XT 7600 Integrated System - Chagas Assay Product Overview
- VITROS XT 7600 Integrated System - High Sensitivity Troponin I Assay
- VITROS XT 7600 Integrated System - High Sensitivity Troponin I Assay Product Overview
- VITROS XT 7600 Integrated System - Nephrocheck Assay
- VITROS XT 7600 Integrated System - Nephrocheck Assay Product Overview
- Ortho Clinical Diagnostics Holdings Plc - Key Competitors
- Ortho Clinical Diagnostics Holdings Plc - Key Employees
- Ortho Clinical Diagnostics Holdings Plc - Key Employee Biographies
- Ortho Clinical Diagnostics Holdings Plc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Ortho Clinical Diagnostics Holdings Plc, Recent Developments
- Sep 26, 2023: Ortho Clinical Diagnostics Holdings Receives 510(k) Clearance for VITROS Immunodiagnostic Products Intact PTH II Reagent Pack
- Sep 08, 2023: Ortho Clinical Diagnostics Holdings Receives 510(k) Clearance for VITROS Immunodiagnostic Products CEA Reagent Pack
- Sep 05, 2023: Ortho-Clinical Diagnostics Obtains CLIA Approval for VITROS Immunodiagnostic Product CA 19-9 Reagent Pack
- Aug 22, 2023: Ortho-Clinical Diagnostics Receives Additional 510(k) clearance for VITROS Immunodiagnostic Product CA 19-9 Reagent Pack
- May 15, 2023: Ortho-Clinical Diagnostics receives DeNovo clearance for VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Calibrator
- May 15, 2023: Ortho-Clinical Diagnostics receives DeNovo clearance for VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total Calibrator
- May 10, 2023: Ortho Clinical Diagnostics receives DeNovo clearance for VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack Test
- May 05, 2023: Ortho Clinical Diagnostics receives DeNovo clearance for VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Reagent Pack
- Apr 27, 2023: Ortho-Clinical Diagnostics receives CLIA approval for VITROS Immunodiagnostic Products Total T3 II Assay
- Apr 27, 2023: Ortho-Clinical Diagnostics receives CLIA approval for VITROS Immunodiagnostic Products T3 Uptake II Assay
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Ortho Clinical Diagnostics Holdings Plc Pipeline Products and Ongoing Clinical Trials Overview
- Ortho Clinical Diagnostics Holdings Plc Pipeline Products by Equipment Type
- Ortho Clinical Diagnostics Holdings Plc Pipeline Products by Indication
- Ortho Clinical Diagnostics Holdings Plc, Key Facts
- Ortho Clinical Diagnostics Holdings Plc, Major Products and Services
- Ortho Clinical Diagnostics Holdings Plc Number of Pipeline Products by Development Stage
- Ortho Clinical Diagnostics Holdings Plc Pipeline Products Summary by Development Stage
- Diagnostic Assay - Thyroid Diseases - Product Status
- Diagnostic Assay - Thyroid Diseases - Product Description
- Enhanced Chemiluminescent High Sensitivity Troponin I Assay - Product Status
- Enhanced Chemiluminescent High Sensitivity Troponin I Assay - Product Description
- Next Generation Circulating Tumor Cell Test - Product Status
- Next Generation Circulating Tumor Cell Test - Product Description
- Next Generation VITROS System - Product Status
- Next Generation VITROS System - Product Description
- ORTHO AutoVue - Rare Sera Assay - Product Status
- ORTHO AutoVue - Rare Sera Assay - Product Description
- ORTHO BioVue - Rare Sera Assay - Product Status
- ORTHO BioVue - Rare Sera Assay - Product Description
- ProMu - Product Status
- ProMu - Product Description
- VITROS 3600 Immunodiagnostic System - High Sensitivity Troponin Assay - Product Status
- VITROS 3600 Immunodiagnostic System - High Sensitivity Troponin Assay - Product Description
- VITROS 3600 Integrated System - Nephrocheck Assay - Product Status
- VITROS 3600 Integrated System - Nephrocheck Assay - Product Description
- VITROS 3600 System With Power Processor - Product Status
- VITROS 3600 System With Power Processor - Product Description
- VITROS 4600 - CRP Ultra (MP) Assay - Product Status
- VITROS 4600 - CRP Ultra (MP) Assay - Product Description
- VITROS 5600 - CRP Ultra (MP) Assay - Product Status
- VITROS 5600 - CRP Ultra (MP) Assay - Product Description
- VITROS 5600 Integrated System - High Sensitivity Troponin Assay - Product Status
- VITROS 5600 Integrated System - High Sensitivity Troponin Assay - Product Description
- VITROS 5600 Integrated System - Nephrocheck Assay - Product Status
- VITROS 5600 Integrated System - Nephrocheck Assay - Product Description
- VITROS Anti-SARS-CoV-2 IgG Test - Product Status
- VITROS Anti-SARS-CoV-2 IgG Test - Product Description
- VITROS ECi/ECiQ Immunodiagnostic System - High Sensitivity Troponin Assay - Product Status
- VITROS ECi/ECiQ Immunodiagnostic System - High Sensitivity Troponin Assay - Product Description
- VITROS XT 7600 Integrated System - Alpha-1 Acid Glycoprotein Assay - Product Status
- VITROS XT 7600 Integrated System - Alpha-1 Acid Glycoprotein Assay - Product Description
- VITROS XT 7600 Integrated System - Alpha-2 Macroglobulin Assay - Product Status
- VITROS XT 7600 Integrated System - Alpha-2 Macroglobulin Assay - Product Description
- VITROS XT 7600 Integrated System - Chagas Assay - Product Status
- VITROS XT 7600 Integrated System - Chagas Assay - Product Description
- VITROS XT 7600 Integrated System - High Sensitivity Troponin I Assay - Product Status
- VITROS XT 7600 Integrated System - High Sensitivity Troponin I Assay - Product Description
- VITROS XT 7600 Integrated System - Nephrocheck Assay - Product Status
- VITROS XT 7600 Integrated System - Nephrocheck Assay - Product Description
- Ortho Clinical Diagnostics Holdings Plc, Key Employees
- Ortho Clinical Diagnostics Holdings Plc, Key Employee Biographies
- Ortho Clinical Diagnostics Holdings Plc, Other Locations
- Ortho Clinical Diagnostics Holdings Plc, Subsidiaries
- Glossary
- Ortho Clinical Diagnostics Holdings Plc Pipeline Products by Equipment Type
- Ortho Clinical Diagnostics Holdings Plc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Alere Inc
- Siemens Healthineers AG
- F. Hoffmann-La Roche Ltd
- Beckman Coulter Inc
- Abbott Laboratories
